Home › Funds › RTW INVESTMENTS, LP › RGEN

RTW INVESTMENTS, LP position in RGEN

REPLIGEN CORP · Health Care

RTW INVESTMENTS, LP reported holding 1,385,398 shares of RGEN (REPLIGEN CORP) in its Q3 2026 13F filing — a position valued at US$266.3M, representing 2.69% of its reported portfolio and ranking #12 among its reported holdings. RTW INVESTMENTS, LP has disclosed RGEN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.39M sh
Reported value held$266.32M
Portfolio Weight2.69%
First reportedQ4 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How RTW INVESTMENTS, LP's RGEN position evolved

RTW INVESTMENTS, LP first disclosed a stake in RGEN in Q4 2025 at 1,064,000 shares (US$174.3M). The position peaked in Q3 2026 at 1,385,398 shares, worth US$266.3M. Across 4 filings, RTW INVESTMENTS, LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,385,398 shares valued at US$266.3M — an increase of 144,761 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.06M $174.35M New
Q1 2026 1.21M $142.09M Add
Q2 2026 1.24M $169.27M Add
Q3 2026 1.39M $266.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (REPLIGEN CORP) is a Health Care company. 34 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has RTW INVESTMENTS, LP held RGEN?

RTW INVESTMENTS, LP has disclosed RGEN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is RTW INVESTMENTS, LP's current position in RGEN?

As of Q3 2026, RTW INVESTMENTS, LP holds 1.39M shares of RGEN (REPLIGEN CORP), valued at $266.32M, representing 2.69% of its reported portfolio and ranking #12.

Has RTW INVESTMENTS, LP been buying or selling RGEN?

In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP increased its position in RGEN. The position peaked in Q3 2026 at 1.39M shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.